Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$78.6M
+11.4% from 2023
Prescriptions
42K
$1,859.31 per claim
Patients
4,770
3,034 prescribers
Total spending, 2024
$78.7M
$16,481.06 per patient
Medicare prescription drug plans paid $78.6M for Pifeltro in 2024, for 42,291 prescriptions and refills to 4,770 patients (up 11.4% from 2023). The average cost per claim was $1,859.31.
California had the highest Medicare cost for Pifeltro in 2024: $14.2M for 6,901 claims, followed by Florida ($7.1M).
Jihad Slim, infectious disease in Newark, NJ, had the highest Medicare cost for Pifeltro in 2024: 437 claims costing $745K.
Pifeltro is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jihad Slim Newark, NJ | Infectious Disease | 437 | 46 | $745K |
| Gennady Nosovitsky Cathedral City, CA | Physician Assistant | 395 | 41 | $681K |
| David J Prelutsky |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,483 | 33,676 | 3,894 | $59.5M |
| 2023 | 2,749 | 38,077 | 4,369 | $70.6M |
| 2024 | 3,034 | 42,291 | 4,770 | $78.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 224 |
| 24 |
| $433K |
| Amarilis Rivera Maldonado Cabo Rojo, PR | General Practice | 232 | 28 | $414K |
| Gebeyehu N Teferi Washington, DC | Internal Medicine | 226 | 24 | $412K |
| Ardis A Moe Los Angeles, CA | Family Practice | 214 | 25 | $408K |
| Noah Lee Oakland Park, FL | Family Practice | 199 | 22 | $400K |
| Waref Azmeh Baton Rouge, LA | Infectious Disease | 230 | 24 | $390K |
| Cyril R Gaultier Palm Springs, CA | Infectious Disease | 178 | 27 | $386K |
| Elizabeth Winthrop Richmond, VA | Nurse Practitioner | 207 | 25 | $366K |
| Christie Basseth Baltimore, MD | Internal Medicine | 207 | 21 | $345K |
| Ann E Stapleton Palm Springs, CA | Internal Medicine | 151 | 17 | $328K |
| Shirin Mazumder Memphis, TN | Infectious Disease | 163 | 18 | $322K |
| Jeffrey Burack Oakland, CA | Internal Medicine | 186 | 21 | $317K |
| Joseph T Lonergan San Diego, CA | Internal Medicine | 162 | 18 | $316K |
| Shawn K Hassler San Francisco, CA | Internal Medicine | 171 | 18 | $315K |
| Clayton O Barbour II Cathedral City, CA | Internal Medicine | 169 | 17 | $299K |
| Beverly E Sha Chicago, IL | Infectious Disease | 161 | 15 | $293K |
| Christopher Foltz Los Angeles, CA | Infectious Disease | 140 | 18 | $285K |
| Virginia I Cafaro San Francisco, CA | Internal Medicine | 119 | 19 | $279K |
| Erin M Duhaime Dallas, TX | Physician Assistant | 150 | 16 | $277K |
| Michelle R Powell Miami, FL | Family Practice | 160 | 21 | $274K |
| Dong Phuong H Nguyen San Francisco, CA | Pharmacist | 46 | 15 | $255K |
| Alireza Farabi Las Vegas, NV | Internal Medicine | 131 | 24 | $255K |
| Gerald R Hamwi Los Angeles, CA | Family Practice | 143 | 14 | $244K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 42,316 | $78.7M |